CD20-specific chimeric antigen receptor-expressing T cells as salvage therapy in rituximab-refractory/relapsed B-cell non-Hodgkin lymphoma
Qian Cheng, Jingwen Tan, Rui Liu, Liqing Kang, Yi Zhang, Erhua Wang, Ying Li, Jian Zhang, Han Xiao, Nan Xu, Minghao Li, Lei Yu, Xin Li
Topics & Concepts
RituximabMedicineCytokine release syndromeCD20LymphomaInternal medicineOncologyChimeric antigen receptorRefractory (planetary science)AntigenImmunologyGastroenterologyClinical trialImmunotherapyCancerBiologyAstrobiologyCAR-T cell therapy researchCancer Immunotherapy and BiomarkersLymphoma Diagnosis and Treatment